Skip to main content

D13.9 vs Z12.13

D13.9 (Benign neoplasm of ill-defined sites within the digestive system) compared with Z12.13 (Encounter for screening for malignant neoplasm of small intestine), from the official CMS tabular data. Z12.13 is the personal-history/screening code for the active disease D13.9 names. MedCoder-derived

Relationship

Review

Condition lifecycle relationship

Z12.13
Encounter for screening for malignant neoplasm of small intestine
D13.9
Benign neoplasm of ill-defined sites within the digestive system

Personal-history or screening code versus the active disease.

Benign neoplasm of this site (intestine)

A personal-history code describes a condition that no longer exists and is no longer being treated, so it is not interchangeable with the active-disease code for the same site.

Source: CMS Table of Neoplasms (site match derived from the code title)

Can these codes be reported together?

History or screening versus active disease. Z12.13 is the personal-history or screening code for the active disease D13.9 names.

Site match derived from the code’s own title against the CMS/CDC Table of Neoplasms. A personal-history code describes a condition that no longer exists and is no longer being treated, so it is not interchangeable with the active-disease code.

Side by side

D13.9Benign neoplasm of ill-defined sites within the digestive systemZ12.13Encounter for screening for malignant neoplasm of small intestine
Billing statusNon-billable header

Report instead: D13.91, D13.99

Billable
ClassificationC00-D49 — NeoplasmsZ00-Z99 — Factors influencing health status and contact with health services
DefinitionBenign neoplasm of ill-defined sites within the digestive system is a non-billable ICD-10-CM category code (D13.9).Encounter for screening for malignant neoplasm of small intestine is a billable ICD-10-CM diagnosis code (Z12.13).
Use additional code
code to identify any family history of malignant neoplasm (Z80.-)

Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources